Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice

Life Sciences

Volumn 68, Issue 16, 2001, Pages 1905-1912

  Bilic, Ivanka ^a   Zoricic, Ivan ^a   Anic, Tomislav ^a   Separovic, Jadranka ^a   Stancic Rokotov, Dinko ^a   Mikus, Darko ^a   Buljat, Gojko ^a   Ivankovic, Davor ^a   Aralica, Gorana ^a   Prkacin, Ingrid ^a   Perovic, Darko ^a   Mise, Stjepan ^a   Rotkvic, Ivo ^a   Petek, Marijan ^a   Rucman, Rudolf ^a   Seiwerth, Sven ^a   Sikiric, Predrag ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Atropine, Pirenzepine; Bromocriptine; Central peripheral dopamine, Prostaglandins; Cimetidine; Domperidone; Haloperidol stomach lesions; Indomethacin; Lansoprazole; Mice; Misoprostol; Omeperazole; Pantroprazole; Pentadecapeptide BPC 157; Ranitidine

Indexed keywords

ATROPINE; BROMOCRIPTINE; CIMETIDINE; DOMPERIDONE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALAN YLGLYCYLLEUCYLVALINE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; HALOPERIDOL; INDOMETACIN; LANSOPRAZOLE; MISOPROSTOL; OMEPRAZOLE; PANTOPRAZOLE; PIRENZEPINE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RANITIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DRUG INDUCED DISEASE; MALE; MOUSE; NONHUMAN; PROSTAGLANDIN SYNTHESIS; STOMACH LESION;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANIMALS; ANTI-ULCER AGENTS; ATROPINE; BENZIMIDAZOLES; BROMOCRIPTINE; CIMETIDINE; DISEASE MODELS, ANIMAL; DOMPERIDONE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HALOPERIDOL; INDOMETHACIN; MALE; MICE; MICE, INBRED STRAINS; MISOPROSTOL; OMEPRAZOLE; PEPTIDE FRAGMENTS; PROTEINS; RANITIDINE; STOMACH DISEASES; SULFOXIDES;

EID: 0035831047     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(00)01025-0     Document Type: Article

References (17)

1. Dopamine agonists and antagonists in duodenal ulcer disease
2. The influence of dopamine agonists and antagonists on gastric lesions in mice
3. Dopamine antagonists induce gastric lesions in rats
4. The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in rats
5. Dopamine agonists prevent duodenal ulcer relapse: A comparative study with famotidine and cimetidine
6. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: The effect on catalepsy and gastric ulcers
7. New model of cytoprotection/adaptive cytoprotection in rats: Endogenous small irritans, antiulcer agents and indomethacin
8. Comparative study of the cytoprotective effects of anticholinergics agents on the mucosal lesions produced by intragastric administration of 0.6 M HCl in rats
9. Omeprazole. An updated review
10. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: A comparative study with omeprazole and lansoprazole
11. Gastric antisecretory activity of lansoprazole in different experimental models: Comparison with omeprazole
12. Effects of proton pump inhibitors on thyroid hormone metabolism in rats: A comparison of UDP-glucuronyltransferase induction
13. Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine and atropine effect in cysteamine lesions in totally gastrectomized rats. A model study for cytoprotective studies
14. Inhibition of cerebrospinal fluid formation by omeprazole
15. Difference between two isozymes of (Na+ + K+)-ATPase in the interaction with omeprazole
16. Fundamentals of gastrointestinal pharmacology
17. Cytoprotection-organoprotection by somatostatin: Gastric and hepatic lesions